[ad_1]
He has successfully passed the Pau Developer Test, which demonstrates his success in detecting pregnancy problems such as pre-eclampsia and life-threatening hypertension, which is often misdiagnosed.
Pregnant women with these conditions suffer from multiple swelling of the ankle, obstructed brain processes or blurred vision, all of which may be covered by changes in the body's condition during pregnancy.
In the absence of symptoms, the condition can be fatal. Researchers have been forced to develop new diagnostic methods and tools to detect them, as the United States struggles to reduce the number of injuries sustained by their mothers after a significant increase.
Researchers at the Wexner Medical Institute at Ohio State University in the United States have developed a dye-based test to identify the proteins associated with preeclampsia in the urine of pregnant women .
Researchers are participating in the FDA's experiment to approve the test, hoping it will be available in homes, clinics and hospitals two years from now.
Preeclampsia is one of the most deadly cases of pregnancy, characterized by high blood pressure in the mother, and also affects some pregnant women during the last third of pregnancy from week 30.
In a new study, published in the Lancet Journal of Clinical Medicine, researchers have shown that this was the case in a study involving 346 pregnant women.
The test revealed that almost all cases, including 25% of women, were in pregnancy.
Tests are currently being conducted in the United States, including Alabama, Connecticut, Pennsylvania, Ohio, and Texas, the country with the highest maternal mortality rate in the country.
Researchers say the test will not be used as a definitive diagnostic method, but it can help doctors determine the severity of symptoms, which may seem normal.
[ad_2]
Source link
